Molecular insight into human platelet antigens: Structural and evolutionary conservation analyses offer new perspective to immunogenic disorders

Transfusion

Volumn 51, Issue 3, 2011, Pages 558-569

  Landau, Meytal ^a,c   Rosenberg, Nurit ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB IX V COMPLEX; THROMBOCYTE ANTIGEN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DNA POLYMORPHISM; GENETIC CONSERVATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LIGAND BINDING; MOLECULAR BIOLOGY; PROTEIN LOCALIZATION;

ANTIGENS, CD; ANTIGENS, HUMAN PLATELET; EVOLUTION, MOLECULAR; GPI-LINKED PROTEINS; HUMANS; IMMUNE SYSTEM DISEASES; INTEGRIN BETA3; MUTATION; NEOPLASM PROTEINS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; POLYMORPHISM, GENETIC;

EID: 79952475877     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02862.x     Document Type: Article

References (53)

1. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, De Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. Nomenclature of human platelet antigens. Vox Sang 2003;85:240-5. (Pubitemid 37247810)
2. Santoso S, Kiefel V, Richter IG, Sachs UJ, Rahman A, Carl B, Kroll H. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia. Blood 2002;99:1205-14.
3. Schuh AC, Watkins NA, Nguyen Q, Harmer NJ, Lin M, Prosper JY, Campbell K, Sutherland DR, Metcalfe P, Horsfall W, Ouwehand WH. A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. Blood 2002;99:1692-8. (Pubitemid 34533043)
4. Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P, Roy S, Bizet AA, Philip A. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J 2006;20:1525-7.
5. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87. (Pubitemid 35283958)
6. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004;432:59-67.
7. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, Arnaout MA. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 2001;294:339-45. (Pubitemid 32963395)
8. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 2008;32:849-61.
9. Springer TA, Zhu J, Xiao T. Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3. J Cell Biol 2008;182:791-800.
10. Newman PJ, Valentin N. Human platelet alloantigens: recent findings, new perspectives. Thromb Haemost 1995; 74:234-9.
11. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004;44:1220-5.
12. Anani Sarab G, Moss M, Barker RN, Urbaniak SJ. Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells. Blood 2009;114:1954-7.
13. Di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice. Am J Pharmacogenomics 2005;5:93-9. (Pubitemid 40593435)
14. Mayrose I, Mitchell A, Pupko T. Site-specific evolutionary rate inference: taking phylogenetic uncertainty into account. J Mol Evol 2005;60:345-53. (Pubitemid 40685127)
15. Landau M, Mayrose I, Rosenberg Y, Glaser F, Martz E, Pupko T, Ben-Tal N. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 2005;33:W299-302. (Web Server issue).
16. Berezin C, Glaser F, Rosenberg J, Paz I, Pupko T, Fariselli P, Casadio R, Ben-Tal N. ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics 2004;20:1322-4. (Pubitemid 38807587)
17. Rosenberg N, Landau M, Luboshitz J, Rechavi G, Seligsohn U. A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation. J Thromb Haemost 2004;2:1167-75. (Pubitemid 40186091)
18. Bairoch A, Apweiler R. The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999. Nucleic Acids Res 1999;27:49-54.
19. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004;32:1792-7. (Pubitemid 38832724)
20. Altschul S, Madden T, Schaffer A, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402. (Pubitemid 27359211)
21. Thompson JD, Higgins DG, Gibson TJ, Clustal W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80. (Pubitemid 24354800)
22. Eddy SR. Hidden Markov models. Curr Opin Struct Biol 1996;6:361-5. (Pubitemid 26197437)
23. Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O'Donovan C, Redaschi N, Yeh LS. The universal protein resource (UniProt). Nucleic Acids Res 2005;33:D154-9.
24. Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the wild-type vonWillebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing vonWillebrand disease mutations. J Biol Chem 2004;279:23327-34. (Pubitemid 38685642)
25. Petrey D, Xiang Z, Tang CL, Xie L, Gimpelev M, Mitros T, Soto CS, Goldsmith-Fischman S, Kernytsky A, Schlessinger A, Koh IY, Alexov E, Honig B. Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins 2003;53:430-5. (Pubitemid 37352202)
26. Bajaj K, Chakrabarti P, Varadarajan R. Mutagenesis-based definitions and probes of residue burial in proteins. Proc Natl Acad Sci U S A 2005;102:16221-6. (Pubitemid 41688895)
27. Sridharan S, Nicholls A, Honig B. A new vertex algorithm to calculate solvent accessible surface area. Biophys J 1992;61:A174.
28. Santoso S, Kroll H, Andrei-Selmer CL, Socher I, Rankin A, Kretzschmar E, Watkins NA, Ouwehand WH. A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1. Transfusion 2006;46:790-9.
29. Peterson JA, Gitter ML, Kanack A, Curtis B, McFarland J, Bougie D, Aster R. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion 2010;50:324-33.
30. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin alpha2beta1. Cell 2000;101:47-56.
31. Celikel R, McClintock RA, Roberts JR, Mendolicchio GL, Ware J, Varughese KI, Ruggeri ZM. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 2003;301:218-21. (Pubitemid 36858476)
32. Dumas JJ, Kumar R, Seehra J, Somers WS, Mosyak L. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science 2003;301:222-6. (Pubitemid 36868962)
33. Sadler JE. Structural biology. A menage a trois in two configurations. Science 2003;301:177-9.
34. Scott PG, McEwan PA, Dodd CM, Bergmann EM, Bishop PN, Bella J. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci U S A 2004;101:15633-8. (Pubitemid 39473539)
35. Mo X, Nguyen NX, McEwan PA, Zheng X, López JA, Emsley J, Li R. Binding of platelet glycoprotein Ibbeta through the convex surface of leucine-rich repeats domain of glycoprotein IX. J Thromb Haemost 2009;7:1533-40.
36. Bromberg Y, Rost B. SNAP: predict effect of nonsynonymous polymorphisms on function. Nucleic Acids Res 2007;35:3823-35. (Pubitemid 47244674)
37. Yue P, Melamud E, Moult J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 2006;7:166.
38. Peretz H, Rosenberg N, Landau M, Usher S, Nelson EJ, Mor-Cohen R, French DL, Mitchell BW, Nair SC, Chandy M, Coller BS, Srivastava A, Seligsohn U. Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3). Hum Mutat 2006;27:359-69.
39. Rosenberg N, Lalezari S, Landau M, Shenkman B, Seligsohn U, Izraeli S. Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome. J Thromb Haemost 2007;5:378-86. (Pubitemid 46139464)
40. Flug F, Espinola R, Liu LX, SinQuee C, DaRosso R, Nardi M, Karpatkin S. A 13-mer peptide straddling the leucine33/ proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Blood 1991;77:1964-9.
41. Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood 1995;85:3028-33.
42. Watkins NA, Schaffner-Reckinger E, Allen DL, Howkins GJ, Brons NH, Smith GA, Metcalfe P, Murphy MF, Kieffer N, Ouwehand WH. HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood 2002;99:1833-9. (Pubitemid 34533060)
43. Stafford P, Garner SF, Huiskes E, Kaplan C, Kekomaki R, Santoso S, Tsuno NH, Watkins NA, Ouwehand WH. Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies. J Thromb Haemost 2008;6:376-83. (Pubitemid 351144610)
44. Santoso S, Kalb R, Kroll H, Walka M, Kiefel V, Mueller- Eckhardt C, Newman PJ. A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa. J Biol Chem 1994; 269:8439-44.
45. Djaffar I, Vilette D, Pidard D, Wautier JL, Rosa JP. Human platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Thromb Haemost 1993;69:485-9. (Pubitemid 23146445)
46. Matsumoto A, Kamata T, Takagi J, Iwasaki K, Yura K. Key interactions in integrin ectodomain responsible for global conformational change detected by elastic network normal-mode analysis. Biophys J 2008;95:2895-908.
47. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt- Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-4. (Pubitemid 26120186)
48. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142-7. (Pubitemid 29177367)
49. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000;101:1013-18. (Pubitemid 30131704)
50. Vijayan KV, Bray PF. Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: enhanced outside-in signaling through the Pro33 variant of integrin beta3. Exp Biol Med (Maywood) 2006;231:505-13.
51. Mor-Cohen R, Rosenberg N, Peretz H, Landau M, Coller BS, Awidi A, Seligsohn U. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3. Thromb Haemost 2007;98:1257-65. (Pubitemid 350239098)
52. Mansour W, Rosenberg N, Hauschner H, Koren A. A novel mutation of a highly conserved residue Asn2Asp of integrin alpha-IIb causes Glanzmann thrombasthenia. J Thromb Haemost 2009;7(Suppl 2):165.PP-TH-084 Abstract.
53. Losonczy G, Rosenberg N, Boda Z, Vereb G, Kappelmayer J, Hauschner H, Bereczky Z, Muszbek L. Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica 2007;92:698-701. (Pubitemid 350144276)